MoonLake Immunotherapeutics MLTX Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about MoonLake Immunotherapeutics's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MoonLake Immunotherapeutics's total liabilities?
- MoonLake Immunotherapeutics (MLTX) reported total liabilities of $146.35M in Q1 2026.
- How has MoonLake Immunotherapeutics's total liabilities changed year-over-year?
- MoonLake Immunotherapeutics's total liabilities increased by 48.3% year-over-year, from $98.68M to $146.35M.
- What is the long-term trend for MoonLake Immunotherapeutics's total liabilities?
- Over 5 years (2020 to 2025), MoonLake Immunotherapeutics's total liabilities has grown at a 96.0% compound annual growth rate (CAGR), from $4.15M to $119.95M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.